Substituted 6-azabenzimidazole compounds
The present disclosure relates generally to certain 6-azabenzimidazole compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions disclosed herein may be used for the treatment or prevention of diseases, disorders, or infections modifiable by hematopoietic progenitor kinase 1 (HPK1) inhibitors, such as HBV, HIV, cancer, and/or a hyper-proliferative disease.
Gilead Sciences, Inc.
C A A A A A C A
C07D A61K A61K A61P A61K A61P C07D A61P
inventional inventional inventional inventional inventional inventional inventional inventional
Scott A. Julian A. Musong Patrick J. Mark J. Gary B. John H. Jennifer A. Rao V. Jennifer L. Jayaraman Jennifer R. Thao D. Joshua J. Suet C. Seung H. Jeff Gayatri
Mitchell Codelli Kim Salvo Bartlett Phillips Conway Loyer-Drew Kalla Cosman Chandrasekhar Lo Perry Van Veldhuizen Yeung Lee Zablocki Balan